Mouse Models of Down Syndrome as a Tool to Unravel the Causes of Mental Disabilities

Down syndrome (DS) is the most common genetic cause of mental disability. Based on the homology of Hsa21 and the murine chromosomes Mmu16, Mmu17 and Mmu10, several mouse models of DS have been developed. The most commonly used model, the Ts65Dn mouse, has been widely used to investigate the neural m...

Full description

Bibliographic Details
Main Authors: Noemí Rueda, Jesús Flórez, Carmen Martínez-Cué
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:Neural Plasticity
Online Access:http://dx.doi.org/10.1155/2012/584071
id doaj-8ae09d403fe2417bbb1e97857820b708
record_format Article
spelling doaj-8ae09d403fe2417bbb1e97857820b7082020-11-24T23:02:08ZengHindawi LimitedNeural Plasticity2090-59041687-54432012-01-01201210.1155/2012/584071584071Mouse Models of Down Syndrome as a Tool to Unravel the Causes of Mental DisabilitiesNoemí Rueda0Jesús Flórez1Carmen Martínez-Cué2Department of Physiology and Pharmacology, Faculty of Medicine, University of Cantabria, Santander 39011, SpainDepartment of Physiology and Pharmacology, Faculty of Medicine, University of Cantabria, Santander 39011, SpainDepartment of Physiology and Pharmacology, Faculty of Medicine, University of Cantabria, Santander 39011, SpainDown syndrome (DS) is the most common genetic cause of mental disability. Based on the homology of Hsa21 and the murine chromosomes Mmu16, Mmu17 and Mmu10, several mouse models of DS have been developed. The most commonly used model, the Ts65Dn mouse, has been widely used to investigate the neural mechanisms underlying the mental disabilities seen in DS individuals. A wide array of neuromorphological alterations appears to compromise cognitive performance in trisomic mice. Enhanced inhibition due to alterations in GABAA-mediated transmission and disturbances in the glutamatergic, noradrenergic and cholinergic systems, among others, has also been demonstrated. DS cognitive dysfunction caused by neurodevelopmental alterations is worsened in later life stages by neurodegenerative processes. A number of pharmacological therapies have been shown to partially restore morphological anomalies concomitantly with cognition in these mice. In conclusion, the use of mouse models is enormously effective in the study of the neurobiological substrates of mental disabilities in DS and in the testing of therapies that rescue these alterations. These studies provide the basis for developing clinical trials in DS individuals and sustain the hope that some of these drugs will be useful in rescuing mental disabilities in DS individuals.http://dx.doi.org/10.1155/2012/584071
collection DOAJ
language English
format Article
sources DOAJ
author Noemí Rueda
Jesús Flórez
Carmen Martínez-Cué
spellingShingle Noemí Rueda
Jesús Flórez
Carmen Martínez-Cué
Mouse Models of Down Syndrome as a Tool to Unravel the Causes of Mental Disabilities
Neural Plasticity
author_facet Noemí Rueda
Jesús Flórez
Carmen Martínez-Cué
author_sort Noemí Rueda
title Mouse Models of Down Syndrome as a Tool to Unravel the Causes of Mental Disabilities
title_short Mouse Models of Down Syndrome as a Tool to Unravel the Causes of Mental Disabilities
title_full Mouse Models of Down Syndrome as a Tool to Unravel the Causes of Mental Disabilities
title_fullStr Mouse Models of Down Syndrome as a Tool to Unravel the Causes of Mental Disabilities
title_full_unstemmed Mouse Models of Down Syndrome as a Tool to Unravel the Causes of Mental Disabilities
title_sort mouse models of down syndrome as a tool to unravel the causes of mental disabilities
publisher Hindawi Limited
series Neural Plasticity
issn 2090-5904
1687-5443
publishDate 2012-01-01
description Down syndrome (DS) is the most common genetic cause of mental disability. Based on the homology of Hsa21 and the murine chromosomes Mmu16, Mmu17 and Mmu10, several mouse models of DS have been developed. The most commonly used model, the Ts65Dn mouse, has been widely used to investigate the neural mechanisms underlying the mental disabilities seen in DS individuals. A wide array of neuromorphological alterations appears to compromise cognitive performance in trisomic mice. Enhanced inhibition due to alterations in GABAA-mediated transmission and disturbances in the glutamatergic, noradrenergic and cholinergic systems, among others, has also been demonstrated. DS cognitive dysfunction caused by neurodevelopmental alterations is worsened in later life stages by neurodegenerative processes. A number of pharmacological therapies have been shown to partially restore morphological anomalies concomitantly with cognition in these mice. In conclusion, the use of mouse models is enormously effective in the study of the neurobiological substrates of mental disabilities in DS and in the testing of therapies that rescue these alterations. These studies provide the basis for developing clinical trials in DS individuals and sustain the hope that some of these drugs will be useful in rescuing mental disabilities in DS individuals.
url http://dx.doi.org/10.1155/2012/584071
work_keys_str_mv AT noemirueda mousemodelsofdownsyndromeasatooltounravelthecausesofmentaldisabilities
AT jesusflorez mousemodelsofdownsyndromeasatooltounravelthecausesofmentaldisabilities
AT carmenmartinezcue mousemodelsofdownsyndromeasatooltounravelthecausesofmentaldisabilities
_version_ 1725637255090929664